| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human ADH6 recombinant protein (Position: E50-K367) was used as the immunogen for the ADH6 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
ADH6 Antibody / Alcohol dehydrogenase 6 is a anti-ADH6 Rabbit antibody Polyclonal (rabbit origin) supplied in Lyophilized format. Recommended for workflows such as Western blot (WB), Flow cytometry (FACS), ELISA with listed reactivity in Human, Mouse, Rat.
Key elements and design rationale
- Target: ADH6
- Antibody details: Rabbit, Polyclonal (rabbit origin), isotype Rabbit IgG
- Format: Lyophilized
- Applications (as listed): WB, FACS, ELISA
Biological background
Structurally, ADH6 is a homodimer of approximately 40 kilodalton subunits, each containing a zinc-binding catalytic domain. The enzyme exhibits broad substrate specificity, oxidizing both ethanol and retinol intermediates. While its catalytic efficiency toward ethanol is lower than ADH1A and ADH1B, ADH6 plays a significant role in the oxidation of aromatic and aliphatic alcohols, making it important for detoxification and vitamin A metabolism. Genetic variations in ADH6 influence alcohol metabolism rates and susceptibility to alcohol-related diseases.
The ADH6 antibody is used in enzymology, metabolism, and toxicology research to study alcohol oxidation and hepatic metabolism. Western blot analysis identifies a 40 kilodalton band corresponding to ADH6, while immunohistochemistry shows strong cytoplasmic staining in hepatocytes. This antibody supports investigation into liver enzyme expression profiles, ethanol metabolism, and the biochemical pathways linking alcohol consumption to liver injury.
Beyond hepatic metabolism, ADH6 participates in retinoid oxidation, converting retinol to retinal, a precursor of retinoic acid involved in gene regulation and differentiation. Dysregulation of ADH6 activity may impact vitamin A homeostasis and oxidative stress responses.
Research relevance and current trends
- Connecting protein-level changes to phenotype using orthogonal readouts (genetic perturbation, transcriptomics, imaging).
- Considering isoforms and post-translational regulation when interpreting protein-level changes.
- Comparing results across species and model systems with matched controls.
Common research applications
- Western blotting: compare relative abundance and activation-state changes across conditions.
- Flow cytometry: quantify target-positive populations and signal shifts at single-cell resolution.
- ELISA: support antibody-based quantification in assay formats where applicable.
Interpret changes in signal alongside appropriate controls and, when relevant, in parallel with total-protein or pathway readouts.
Notes for experimental interpretation
- Signal can reflect expression level, isoform composition, and post-translational state; interpret results in the context of your model system and stimuli.
- Species differences and sample matrices can influence epitope recognition; prioritize matched controls and orthogonal confirmation when feasible.
Antibody notes: Polyclonal antibodies recognize multiple epitopes, which can broaden the epitope footprint and may increase sensitivity in some contexts.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
